Skip to main content

<>Company Overview

480 Biomedical is a clinical stage company developing novel bioresorbable scaffold technologies for the vasculature. 480 Biomedical was founded to advance clinical-stage scaffold technologies from Arsenal Medical.

Learn more about Arsenal Medical at

Bioresorbable Scaffold Technology

480 Biomedical's self-expanding scaffold technology platform employs a unique composite design that strikes an optimal balance of strength, flexibility and bioresorption.

Lead Product: Peripheral Artery Disease

Our lead product is the proprietary Stanza™ bioresorbable, drug eluting, scaffold and delivery system for use in treating peripheral artery disease in the superficial femoral artery, a condition that is poorly addressed today.


480 Biomedical Awarded $1 Million Phase II NHLBI Contract to Advance Bioresorbable Scaffold for Pediatric Pulmonary Artery Stenosis

July 9, 2014

View press release

BSI Certificate Awarded

December 11, 2013

View press release

Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.